Simon J Crabb (Simon Crabb)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

British journal of cancer

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Jones, Simon J Crabb, Mark Linch, Alison J Birtle, John McGrane, Deborah Enting, Robert Stevenson, Kin Liu, Bihani Kularatne, Syed Anwer Hussain
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective. British journal of cancer 130 (6) (2024)
Robert J Jones, Simon J Crabb, Mark Linch, Alison J Birtle, John McGrane, Deborah Enting, Robert Stevenson, Kin Liu, Bihani Kularatne, Syed Anwer Hussain
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective. British journal of cancer 130 (6) (2024)
Robert J Jones, Simon J Crabb, Mark Linch, Alison J Birtle, John McGrane, Deborah Enting, Robert Stevenson, Kin Liu, Bihani Kularatne, Syed Anwer Hussain
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective. British journal of cancer 130 (6) (2024)
Robert J Jones, Simon J Crabb, Mark Linch, Alison J Birtle, John McGrane, Deborah Enting, Robert Stevenson, Kin Liu, Bihani Kularatne, Syed Anwer Hussain
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective. British journal of cancer (2024)
Megan Giles, Simon J Crabb
Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes. Research and reports in urology 15 (2023)
Simone Critchlow, Ash Bullement, Simon J Crabb, Robert J Jones, Katerina Christoforou, Amerah Amin, Ying Xiao, Venediktos Kapetanakis, Ágnes Benedict, Jane Chang, Mairead Kearney, Anthony Eccleston
Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland. Future oncology (London, England) (2023)
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, Ignacio Duran, Simon J Crabb, Michiel S Van Der Heijden, Bernadett Szabados, Albert Font Pous, Gwenaelle Gravis, Urbano Anido Herranz, Andrew S Protheroe, Alain Ravaud, Denis Maillet, Maria Jose Mendez, Cristina Suarez, Mark Linch, Aaron Prendergast, Pieter-Jan van Dam, Diana Stanoeva, Sofie Daelemans, Sanjeev Mariathasan, Joy S Tea, Kelly Mousa, Romain Banchereau, Daniel Castellano
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Nature medicine (2023)
Simon J Crabb, Syed Hussain, Eileen Soulis, Samantha Hinsley, Laura Dempsey, Avril Trevethan, YeePei Song, Jim Barber, John Frew, Joanna Gale, Guy Faust, Susannah Brock, Ursula McGovern, Omi Parikh, Deborah Enting, Santhanam Sundar, Gihan Ratnayake, Kathryn Lees, Alison Jane Birtle, Thomas Powles, Robert J Jones
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Matteo Santoni, Francesco Massari, Sergio Bracarda, Giuseppe Procopio, Michele Milella, Ugo De Giorgi, Umberto Basso, Gaetano Aurilio, Antonio Russo, Angelo Martignetti, Mimma Rizzo, Giacomo Cartenì, Enrique Grande, Marc R Matrana, Simon J Crabb, Nuno Vau, Giulia Sorgentoni, Alessia Cimadamore, Rodolfo Montironi, Nicola Battelli
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor? Diagnostics (Basel, Switzerland) 11 (1) (2021)
Simon J Crabb, Sarah J Danson, James W F Catto, Syed Hussain, Danna Chan, Denise Dunkley, Nichola Downs, Ellice Marwood, Laura Day, Geoff Saunders, Michelle Light, Amy Whitehead, Deborah Ellis, Naveed Sarwar, Deborah Enting, Alison Jane Birtle, Bernadette Johnson, Robert A Huddart, Gareth Griffiths
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE). Clinical cancer research : an official journal of the American Association for Cancer Research 27 (7) (2021)
Bradleigh Whitton, Haruko Okamoto, Matthew Rose-Zerilli, Graham Packham, Simon J Crabb
V-ATPase Inhibition Decreases Mutant Androgen Receptor Activity in Castrate-resistant Prostate Cancer. Molecular cancer therapeutics 20 (4) (2021)
Matteo Santoni, Daniel Y Heng, Sergio Bracarda, Giuseppe Procopio, Michele Milella, Camillio Porta, Marc R Matrana, Giacomo Cartenì, Simon J Crabb, Ugo De Giorgi, Umberto Basso, Cristina Masini, Fabio Calabrò, Maria Giuseppa Vitale, Daniele Santini, Francesco Massari, Luca Galli, Giuseppe Fornarini, Riccardo Ricotta, Sebastiano Buti, Paolo Andrea Zucali, Orazio Caffo, Franco Morelli, Francesco Carrozza, Angelo Martignetti, Alain Gelibter, Roberto Iacovelli, Alessandra Mosca, Francesco Atzori, Nuno Vau, Lorena Incorvaia, Cinzia Ortega, Marina Scarpelli, Antonio López-Beltran, Liang Cheng, Vittorio Paolucci, Jeffrey Graham, Erin Pierce, Sarah Scagliarini, Pierangela Sepe, Elena Verzoni, Sara Merler, Mimma Rizzo, Giulia Sorgentoni, Alessandro Conti, Francesco Piva, Alessia Cimadamore, Rodolfo Montironi, Nicola Battelli
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors. Cancers 12 (1) (2019)
Alberto Martini, Rachel Jia, Bart S Ferket, Nikhil Waingankar, Elizabeth R Plimack, Simon J Crabb, Lauren C Harshman, Evan Y Yu, Thomas Powles, Jonathan E Rosenberg, Sumanta Kumar Pal, Ulka N Vaishampayan, Andrea Necchi, N Peter Wiklund, Reza Mehrazin, Madhu Mazumdar, John P Sfakianos, Matthew D Galsky
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer. Cancer 125 (18) (2019)
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, Ignacio Duran, Simon J Crabb, Michiel S Van Der Heijden, Bernadett Szabados, Albert Font Pous, Gwenaelle Gravis, Urbano Anido Herranz, Andrew S Protheroe, Alain Ravaud, Denis Maillet, Maria Jose Mendez, Cristina Suarez, Mark Linch, Aaron Prendergast, Pieter-Jan van Dam, Diana Stanoeva, Sofie Daelemans, Sanjeev Mariathasan, Joy S Tea, Kelly Mousa, Romain Banchereau, Daniel Castellano
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Nature medicine 25 (11) (2019)
Roland Seiler, Ewan A Gibb, Natalie Q Wang, Htoo Zarni Oo, Hung-Ming Lam, Kim E van Kessel, Charlotte S Voskuilen, Brian Winters, Nicholas Erho, Mandeep M Takhar, James Douglas, Funda Vakar-Lopez, Simon J Crabb, Bas W G van Rhijn, Elisabeth E Fransen van de Putte, Ellen C Zwarthoff, George N Thalmann, Elai Davicioni, Joost L Boormans, Marc Dall'Era, Michiel S van der Heijden, Jonathan L Wright, Peter C Black
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (16) (2018)
Bradleigh Whitton, Haruko Okamoto, Graham Packham, Simon J Crabb
Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer. Cancer medicine 7 (8) (2018)
Sergio Regufe da Mota, Sarah Bailey, Rosemary A Strivens, Annette L Hayden, Leon R Douglas, Patrick J Duriez, M Teresa Borrello, Hanae Benelkebir, A Ganesan, Graham Packham, Simon J Crabb
LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models. Cancer cell international 18 (2018)

Simon J Crabb.css-eqlu8i{font-size:small;padding-left:4px;} (Simon Crabb)

Publication Activity (10 Years)

Top Topics

Top Venues

Simon J Crabb (Simon Crabb)